Report: Cost effectiveness review of blood pressure interventions

High blood pressure is one of the key risk factors contributing to premature death and disability in England. 

Public Health England (PHE) established the Blood Pressure Systems Leadership Board (BPSLB), bringing together partners across national and local government, the health system, voluntary sector and academia, to develop a system-wide initiative to tackle high blood pressure. In developing this work the BPSLB has taken a systematic approach to considering the cost effectiveness of selected policies and interventions to inform the way forward. 

Optimity was commissioned by PHE to support the BPSLB; specifically to deliver a short assessment of the cost effectiveness of selected interventions. A sub-group of the BPSLB was established to steer the work and work collaboratively with Optimity.

You may also be interested in